drug · protein
patient view →denileukin diftitox
pre_registrationupdated 2mo agoby $CTOR CITIUS ONCOLOGY, INC.🔗 ChEMBL
community read0 votes
Protein drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 12 investigational indications.
targets
Interleukin-2 receptorElongation factor 2
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that